Atlas Trials

Effect of Administration of 3rd Generation Cephalosporin on the Digestive Carrying of 3rd Generation Cephalosporin-resistant Enterobacteriaceae (CEF-IMPACT)

Clinical trial NCT03922919 · UNKNOWN

Trial details

NCT number
NCT03922919
Sponsor
Centre Hospitalier Universitaire de Besancon
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Infectious Disease - Resistant Enterobacteriaceae (Diagnosis)
Start date
2018-04-03
Primary completion
2020-04-03
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.